ArticleNeurosurgical review2006
Intraorbital lymphomas: neurosurgical experiences and management strategies.
Article in Neurosurgical review, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immunoglobulin G4-related disease (IgG4-RD) in the orbit: mucosa-associated lymphoid tissue (MALT)-type lymphomas.Medical science monitor : international medical journal of experimental and clinical research · 2015Article
- Cavernous malformations of the orbit: a distinct entity? A review of own experiences.Neurosurgical review · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intraorbital lymphoma is a rare event. The aim of this study was to evaluate the clinical features, management, and outcome of patients with intraorbital lymphoma. The data of twenty-one individuals (12 women, nine men, aged 33 years to 84 years, mean age 62 years) with intraorbital lymphoma diagnosed between 1994 and 2003 were reviewed. Fifteen patients had no signs of systemic lymphoma disease. After the diagnosis of lymphoma had been surgically confirmed, chemotherapy alone was administered to seven patients, only radiotherapy was employed in nine, and both therapies were administered to five patients. With this treatment it was possible to obtain relief of orbital symptoms in 14 patients (67%) for at least 1 year. Three patients remain unchanged in their decreased visual capabilities. Local recurrence was observed in four cases and was treated with chemotherapy. Individualized microsurgical approaches to the orbit and adequate adjuvant therapy (radiotherapy, steroids, and chemotherapy, separate or in combination) are necessary to achieve satisfactory remission of orbital lymphomas.
Indexed as
Identifiers
16397817What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.